NVIDIA Projects 72% FY2027 Growth with New AI Systems, $265 Target
NVIDIA introduced Blackwell and Vera Rubin full-stack AI systems, projecting FY2027 revenue growth of ~72% at ~24x P/E and ~13x P/S. It’s deploying GPUs and quantum-AI models for drug discovery while JPMorgan set a $265 target (32% upside) as Alphabet trails by under $200B.
1. Full-Stack AI Systems Launched
NVIDIA rolled out its Blackwell and Vera Rubin AI systems, marking a shift from standalone GPUs to integrated AI factories designed for end-to-end model training, inference and deployment at scale across cloud and edge environments.
2. Quantum-AI Models in Drug Discovery
Leveraging its high-performance GPUs and newly announced quantum-AI architectures, NVIDIA is collaborating with biopharmaceutical firms to accelerate molecular simulations and candidate screening, aiming to reduce drug development timelines.
3. Valuation Metrics and Analyst Targets
Despite trading at roughly 24x forward P/E and 13x forward P/S, NVIDIA forecasts about 72% revenue growth for FY2027, prompting a $265 price target from major firms that implies a 32% upside from current levels.
4. Market Value Race with Alphabet
NVIDIA remains the leading semiconductor company by market capitalization, though its valuation gap to Alphabet has narrowed below $200 billion, highlighting intensifying competition among tech’s largest firms.